The group observed that ELISA analysis of combined flotillin 2 and Parkinsonism associated deglycase (PARK7) had a value of 68% sensitivity and 93% specificity, distinguishing PCa patients with healthy controls. Here, FLOT2 is linked to posterior cortical atrophy.